Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abhydrolase domain containing 17A pseudogene (ENSG00000278552) is classified as a human pseudogene related to the ABHD17A family, which typically includes alpha/beta hydrolase fold-containing enzymes[1]. As a pseudogene, it does not encode a functional protein product and has no established biological function, druggability, or relevance to disease. It is annotated under a number of alternative names reflecting its sequence similarity to functional ABHD17 enzymes and related family members. There is no evidence for therapeutic targeting, biomarker use, disease association, or pharmacological interaction, consistent with its status as a non-coding pseudogene[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Abhydrolase domain containing 17A pseudogene.